EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetic and oral bioavailability study of schaftoside in rats

Yuan Lin, Hongqiang Wang, Shihui Xu, Chang Liu iD, Chengzhong Zhang

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Yuan Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wenling Hospital of Traditional Chinese Medicine, Wenling, China. Hauptthemen laut MEDLINE: Biological Availability, Rats, Sprague-Dawley, Tandem Mass Spectrometry. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Shanghai City Science and Technology Innovation Action Technical Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A simple and sensitive LC–tandem mass spectrometry method was established and validated for the determination of schaftoside in rat plasma. After prepared by protein precipitation with acetonitrile, schaftoside and internal standard were separated on a Waters HSS T3 column using acetonitrile containing 0.1% formic acid and 0.1% formic acid in water as the mobile phase by gradient elution. The method showed excellent linearity over the range of 0.5–500 ng/mL with acceptable intra‐ and inter‐day precision, accuracy, matrix effect, and recovery. The stability assay indicated that schaftoside was stable during the sample acquisition, preparation, and storage. The method was applied to a pharmacokinetic study of schaftoside in rats. The result suggested that after intravenous administration at a dose of 1 mg/kg, schaftoside was quickly eliminated from the plasma with an elimination half‐life of 0.58 h. After oral administration at doses of 5, 10, and 20 mg/kg, schaftoside was quickly absorbed into the plasma and reached the peak concentration ( C max ) of 45.1–104.99 ng/mL at 0.67–1.17 h. The increase of exposure (area under the curve) was linear with the increase of dose. The oral bioavailability was 0.42%–0.71% in the range of 5–20 mg/kg.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological AvailabilityRats, Sprague-DawleyTandem Mass SpectrometryAnimalsRatsMaleAdministration, OralReproducibility of ResultsLinear ModelsChromatography, LiquidLimit of DetectionSensitivity and SpecificityGlycosidesDrug Stability

Stichwörter der Autor:innen

LC–MS/MSbioavailabilitypharmacokineticschaftoside

Substanzen

Glycosides

Autor:innen und Institutionen

  • Wenling Hospital of Traditional Chinese Medicine, Wenling, China.
  • Fuyang Institute for Food and Drug Control, Fuyang, China.
  • Faculty of Pharmacy, Naval Medical University, Shanghai, China.

ORCID-Profile: Chang Liu

Förderung

  • Shanghai City Science and Technology Innovation Action Technical Program

Zitieren

APA

Lin, Y., Wang, H., Xu, S., Liu, C., & Zhang, C. (2024). Pharmacokinetic and oral bioavailability study of schaftoside in rats. Biomedical Chromatography. https://doi.org/10.1002/bmc.5892

Vancouver

Lin Y, Wang H, Xu S, Liu C, Zhang C. Pharmacokinetic and oral bioavailability study of schaftoside in rats. Biomedical Chromatography. 2024. doi:10.1002/bmc.5892

BibTeX
@article{Lin2024,
  author = {Lin, Yuan and Wang, Hongqiang and Xu, Shihui and Liu, Chang and Zhang, Chengzhong},
  title = {Pharmacokinetic and oral bioavailability study of schaftoside in rats},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5892}
}
Kostenlos starten →